Product complaint # pc-(b)(4).Date sent to the fda: (b)(4) 2018.An opened box of product code (b)(4), lot mam223 containing thirty-five unopened samples of a different product code (b)(4) , lot lpm513 were returned for analysis.During the visual inspection of box, a mismatched between box and the individual foils inside were observed.For this reason, a characterization of samples was conducted, and the following was observed: thirty-five foils were examined and no defects were found on the packages.The samples were opened, and the swage and attachment area of the needles were as expected.Also, the samples were examined by needle characteristic on point type, needle type and needle curvature and suture characteristic and the product contained in each packet belong to product code (b)(4), lot lpm513.In addition, the manufacturing date is on (b)(4), 2017.The box with the product code (b)(4), lot mam223 were examined and excessive manipulation could be observed.Also, the manufacturing date is on (b)(4), 2018.Also, the manufactured dates were reviewed there are a difference of a month of separation between the manufacture date of the reported lots.The manufacturing records were reviewed, and the manufacturing/packaging criteria were met prior to the release of this batch.According to manufactured dates and that the box was received opened a mix of product could not be happened in our manufacturing sites and the assignable cause of the assembly incorrect implantable is an improper handling and the reported complaint.
|